Options for Raising Capital in a Down Market

4:15 PM - 5:15 PM (PDT), Tuesday, June 14, 2022

The current stock market environment for small biotechs is tough even by historical standards.  Many biotechs are now trading below cash value and IPOs have slowed significantly.  In the current environment, companies are having to consider alternative methods for raising capital to advance clinical trials and R&D pipelines.  This panel will discuss some of these specialized financing mechanisms, such as private investments in public entities (PIPEs), royalty deals, and other structured deals that use pipelines as collateral.

Moderator
photo
Executive Vice President and Chief Financial Officer
Gritstone bio
Speakers
photo
Managing Director
Runway Growth Capital
photo
Partner
Oberland Capital Management
photo
EVP, Head of Research & Investments
Royalty Pharma Management, LLC